Fortis Healthcare
add_icon

Fortis Healthcare

837.85
-39.50
(-4.50%)
Market Cap
63,254.17 Cr
PE Ratio
61.97
Volume
24,33,292.00
Day High - Low
880.55 - 832.00
52W High-Low
1,104.30 - 766.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
63,254.17 Cr
EPS
13.80
PE Ratio
61.97
PB Ratio
6.70
Book Value
131.07
EBITDA
2,135.60
Dividend Yield
0.11 %
Sector
Hospitals
Return on Equity
10.47
Debt to Equity
0.32
Analyst Rating and Forecast
- By Refinitiv from17 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+88.24 %
+88.24 %
Hold
Hold+11.76 %
+11.76 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
NTK appeals Tokyo court ruling in Daiichi Sankyo caseToday
NTK has submitted an appeal against a Tokyo court ruling related to the Daiichi Sankyo case to the Tokyo High Court on September 24, 2026.
positive
Fortis Healthcare has signed definitive agreements with SLJ Society to provide healthcare services for a 400+ bed super specialty hospital in Ashok Vihar, Delhi. The deal includes a ₹567 crore loan facility.
neutral
Fortis Healthcare Limited filed a Special Leave Petition in the Supreme Court on September 16, 2026, challenging the Delhi High Court's August 31 order in the Daiichi Sankyo case.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
8,889.00
#1 1,27,810.18
58.92
#1 25,420.10
15.58
#1 2,003
38.41
52.23
1,014.00
98,686.92
69.97
8,536.10
18.82
1,442
4.87
44.14
759.40
66,194.81
184.63
4,768.80
11.25
427
-68.70
45.24
837.85
#4 63,254.17
#5 61.97
#2 9,178.50
#7 16.93
#3 1,064
#7 2.25
28.56
1,495.40
40,206.49
73.35
4,508.90
19.56
554
-1.07
56.91
1,861.40
38,039.72
46.99
7,996.30
#1 43.43
811
5.39
45.94
780.15
32,766.81
172.89
3,930.80
28.16
242
-56.00
48.94
500.00
15,849.15
85.92
2,124.50
20.92
168
#1 44.36
47.48
1,374.20
13,956.26
49.40
1,746.90
11.49
282
16.17
32.77
286.35
12,368.34
#1 41.58
1,711.00
19.99
274
35.27
55.34
Growth Rate
Revenue Growth
16.93 %
Net Income Growth
31.48 %
Cash Flow Change
12.47 %
ROE
18.57 %
ROCE
23.02 %
EBITDA Margin (Avg.)
10.39 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1,085
1,152
1,150
1,024
1,106
1,176
1,257
1,630
1,164
1,229
1,258
1,175
1,108
1,081
1,156
1,164
1,528
1,170
1,277
1,178
1,133
614
1,029
1,205
1,278
1,733
1,475
1,487
1,391
1,519
1,682
1,586
1,669
1,667
1,788
1,699
1,803
1,873
2,006
1,975
2,032
2,198
2,381
2,277
2,375
2,573
Expenses
1,022
986
1,087
1,066
1,091
1,059
1,097
1,023
1,045
1,071
1,138
1,069
1,907
1,034
1,172
1,193
1,069
996
1,028
1,012
987
709
875
987
1,055
1,135
1,178
1,180
1,157
1,237
1,304
1,283
1,372
1,386
1,440
1,396
1,405
1,516
1,613
1,553
1,625
1,676
1,775
1,805
1,845
2,008
EBITDA
62
166
62
-42
15
118
160
607
118
158
120
106
-799
47
-16
-29
459
174
250
166
146
-96
155
218
223
598
297
307
234
282
378
302
297
282
349
303
398
356
393
422
406
522
606
472
530
566
Operating Profit %
3 %
4 %
-2 %
-5 %
-2 %
6 %
8 %
10 %
7 %
7 %
5 %
5 %
-76 %
1 %
-3 %
-8 %
10 %
13 %
15 %
13 %
11 %
-17 %
12 %
16 %
16 %
20 %
19 %
20 %
16 %
17 %
19 %
18 %
16 %
16 %
19 %
17 %
21 %
18 %
19 %
19 %
19 %
23 %
24 %
20 %
22 %
21 %
Depreciation
61
53
0
0
72
48
52
60
63
59
61
59
60
57
56
60
60
71
71
70
80
72
74
73
72
73
75
76
77
74
77
83
82
79
84
87
92
91
95
97
102
102
106
120
122
122
Interest
37
34
30
32
38
42
46
75
67
64
66
63
64
76
85
111
65
51
49
48
57
41
42
42
41
38
40
38
30
31
33
33
32
32
32
33
35
35
36
45
68
70
75
86
84
80
Profit Before Tax
-22
88
44
-58
-96
28
62
472
-11
35
-7
-17
-924
-87
-157
-201
334
52
130
48
9
-208
38
103
110
486
182
193
126
176
268
186
183
171
233
183
271
230
261
279
237
351
425
266
324
363
Tax
-10
-9
-17
-29
-8
3
24
19
26
12
17
3
-9
-34
-15
-20
183
-26
6
118
50
-20
23
49
48
56
51
51
39
42
50
44
45
47
49
49
68
56
68
25
49
84
97
68
53
90
Net Profit
-12
97
61
-29
-88
25
38
453
-38
23
-24
-19
-914
-53
-142
-180
151
78
124
-69
-41
-188
16
54
62
431
131
142
87
134
218
142
138
124
184
134
203
174
193
254
188
267
329
197
271
273
EPS in ₹
-0.38
2.01
1.19
-0.65
-1.91
0.35
0.68
9.49
-0.79
0.10
-0.88
-0.71
-17.97
-1.36
-3.21
-3.06
1.80
0.90
1.47
-1.01
-0.59
-2.37
-0.05
0.40
0.57
3.49
1.42
1.55
0.90
1.62
2.71
1.72
1.76
1.48
2.30
1.78
2.37
2.20
2.34
3.28
2.44
3.45
4.26
2.57
3.52
3.53

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
15,966
Fixed Assets
4,218
3,776
5,419
4,992
8,477
8,802
8,799
9,416
9,426
9,874
10,424
12,230
Current Assets
1,636
1,434
1,775
1,282
1,667
941
1,037
1,133
1,406
1,421
1,471
1,819
Capital Work in Progress
228
201
268
226
450
204
165
194
228
542
407
434
Investments
616
1,449
1,878
1,732
270
175
186
104
210
230
169
243
Other Assets
2,554
1,807
2,152
1,672
2,755
2,167
2,005
2,172
2,569
2,643
2,692
3,059
Total Equity & Liabilities
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
15,966
Current Liabilities
1,602
1,476
1,927
2,134
3,591
2,579
1,233
1,269
1,426
3,170
1,607
2,115
Non Current Liabilities
1,813
1,616
1,480
1,171
1,248
1,563
3,204
3,607
2,907
1,563
2,915
3,683
Total Equity
4,201
4,140
6,311
5,317
7,113
7,206
6,718
7,008
8,100
8,556
9,169
10,169
Reserve & Surplus
3,585
3,534
4,626
3,543
5,846
5,906
5,365
5,423
6,487
6,908
8,162
9,141
Share Capital
463
463
518
519
755
755
755
755
755
755
755
755

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-66
-38
225
-513
799
-627
212
-153
-22
125
-70
228
Investing Activities
213
122
-1,001
-333
-3,279
64
-131
-501
-373
-889
-780
-1,537
Operating Activities
24
195
967
493
-179
172
486
865
822
1,100
1,424
1,601
Financing Activities
-304
-354
259
-672
4,257
-862
-143
-517
-471
-87
-714
164

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
26.32 %
0.00 %
23.24 %
23.31 %
25.26 %
26.77 %
27.40 %
27.17 %
27.90 %
27.84 %
25.97 %
25.20 %
DIIs
13.44 %
15.20 %
15.66 %
15.50 %
16.72 %
17.44 %
19.94 %
20.38 %
20.70 %
22.16 %
26.55 %
29.35 %
31.15 %
32.31 %
30.73 %
30.05 %
29.46 %
29.79 %
29.14 %
29.33 %
31.35 %
32.23 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.96 %
15.16 %
15.98 %
14.89 %
13.96 %
13.58 %
12.92 %
12.39 %
12.05 %
11.80 %
11.13 %
11.04 %
10.82 %
10.47 %
10.36 %
10.21 %
10.22 %
10.17 %
10.14 %
10.14 %
9.96 %
9.87 %
Others
41.43 %
38.47 %
37.20 %
38.44 %
38.15 %
37.82 %
35.98 %
36.06 %
36.08 %
34.86 %
4.83 %
28.44 %
3.63 %
2.75 %
2.48 %
1.81 %
1.75 %
1.70 %
1.65 %
1.53 %
1.54 %
1.53 %
No of Share Holders
0
1,09,889
1,44,634
1,66,743
1,54,572
1,56,881
1,60,762
1,58,455
1,37,894
1,35,047
1,31,516
1,35,664
1,57,165
1,54,260
2,04,184
2,21,750
2,18,329
2,05,373
2,20,766
2,33,156
2,26,685
2,20,743

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 1 1 1 1
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.14 0.13 0.11

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 Jul 2023 DIVIDEND Dividend
₹ 1.00 /share
20 Jul 2023 289.05 328.75
24 Jul 2024 DIVIDEND Dividend
₹ 1.00 /share
24 Jul 2024 469.50 487.45
02 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
02 Aug 2024 471.55 505.05
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 601.65 623.10
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 581.00 651.05
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 682.75 685.85
25 Jul 2025 DIVIDEND Dividend
₹ 1.00 /share
25 Jul 2025 685.85 846.55
06 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Aug 2025 850.05 867.90
11 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Aug 2025 773.45 897.45
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 1,030.70 992.70
13 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Feb 2026 857.30 928.55
22 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 May 2026 970.70 967.30
24 Jul 2026 DIVIDEND Dividend
₹ 1.00 /share
24 Jul 2026 967.30 943.90
06 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Aug 2026 952.70 925.00
11 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Aug 2026 963.10 955.00

Announcements

Closure of Trading Window6 hrs ago
Update On Material Litigation Filed By Northern TK Venture Pte Ltd. (NTK) The Promoter Shareholder Of The Company Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan7 hrs ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release9 days ago
Intimation For Signing The Definitive Agreements By Fortis Hospotel Limited (Wholly Owned Subsidiary Of The Company) To Provide Healthcare Services To A 400+ Bedded Super Specialty Hospital In Ashok Vihar New Delhi9 days ago
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 About Filing Of Special Leave Petition (SLP) Before The HonBle Supreme Court Of India9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Update On Material Litigation Filed By Northern TK Venture Pte Ltd. (NTK) The Promoter Shareholder Of The Company Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan.Sep 11, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptSep 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2026
Announcement Under Regulation 30 (LODR) - Regarding Order Passed By The HonBle Delhi High Court In Relation To Certain Applications Filed By Daiichi Sankyo Company Limited Inter Alia The Company. Detailed Disclosure Is Attached.Sep 01, 2026
ESG RatingAug 24, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 11, 2026
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 11, 2026
Summary Of The Proceedings Of The 30Th Annual General Meeting.Aug 11, 2026
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 07, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 06, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementAug 06, 2026
Financial Results Quarter Ended June 30 2026Aug 06, 2026
Board Meeting Outcome for Outcome Of Board MeetingAug 06, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2026
Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30 2026.Jul 30, 2026
Intimation On Tax Deduction At Source (TDS) / Withholding Tax On DividendJul 21, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 20, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2026
Closure Of Register Of MembersJul 17, 2026
Record Date For Payment Of DividendJul 17, 2026
Letters Sent To The ShareholdersJul 17, 2026
Business Responsibility and Sustainability Reporting (BRSR)Jul 17, 2026
Regulation 53 (1) Annual Report.Jul 17, 2026
Reg. 34 (1) Annual Report.Jul 17, 2026
Notice Of Annual General MeetingJul 17, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJul 08, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 08, 2026
Board Meeting Outcome for Board Meeting Outcome Dated July 08 2026Jul 08, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 03, 2026
Closure of Trading WindowJun 24, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements)Regulations 2015 (SEBI Listing Regulations)-Income Tax Order For Wholly Owned SubsidiaryJun 17, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
TRUSTMF Mid Cap Fund Direct-Growth
0.00%
-85825
-1.89%
-2.32%
TRUSTMF Multi Cap Fund Direct-Growth
0.00%
-75586
-1.05%
-1.20%
Baroda BNP Paribas Services Fund Direct-Growth
1.09%
75000
1.09%
1.09%
Axis Services Opportunities Fund Direct-Growth
4.57%
-55318
-0.18%
-0.17%
LIC MF Consumption Fund Direct-Growth
0.00%
-50256
-0.99%
-1.01%
The Wealth Company Mid Cap Fund Direct-Growth
2.12%
40000
2.12%
2.12%
Motilal Oswal BSE Midcap 150 Momentum 30 Index Fund Direct-Growth
3.59%
29347
-0.35%
3.59%
The Wealth Company Multi Asset Allocation Fund Direct-Growth
0.00%
-19400
-0.95%
-0.63%
JioBlackRock Arbitrage Fund Direct-Growth
0.22%
13950
0.22%
0.22%
Old Bridge Arbitrage Fund Direct-Growth
0.57%
12400
0.50%
0.49%
UTI Nifty 500 Index Fund Direct-Growth
0.24%
2867
0.24%
0.24%
Unifi Dynamic Asset Allocation Fund Direct-Growth
0.01%
2325
0.01%
0.01%
Groww Arbitrage Fund Direct-Growth
0.25%
2325
0.25%
0.25%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
4.50%
2000
-0.05%
0.18%
Tata Nifty Midcap 150 Index Fund Direct-Growth
1.12%
1159
-0.07%
-0.11%
Kotak Nifty Alpha 50 Index Fund Direct-Growth
1.06%
752
-0.09%
-0.14%
Aditya Birla Sun Life BSE 500 Momentum 50 Index Fund Direct-Growth
2.12%
634
-0.17%
-0.21%
DSP Nifty Healthcare Index Fund Direct-Growth
4.07%
609
-0.21%
-0.51%
JioBlackRock Sector Rotation Fund Direct-Growth
0.39%
578
0.01%
0.11%
Kotak Nifty Midcap 150 Index Fund Direct-Growth
1.11%
490
-0.07%
-0.12%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
1.11%
-379
-0.07%
-0.11%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.57%
299
-0.02%
-0.04%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.77%
-265
-0.07%
-0.13%
AlphaGrep Multi Asset Allocation Fund Direct-Growth
0.00%
-209
-0.04%
0.00%
Zerodha Life Cycle Fund 2041 Direct-Growth
0.45%
179
-0.01%
0.45%

Technical Indicators

RSI(14)
Neutral
38.54
ATR(14)
Volatile
18.57
STOCH(9,6)
Neutral
49.82
STOCH RSI(14)
Neutral
69.01
MACD(12,26)
Bearish
-0.16
ADX(14)
Weak Trend
9.69
UO(9)
Bearish
36.70
ROC(12)
Downtrend And Accelerating
-3.59
WillR(14)
Neutral
-72.02

About Fortis Healthcare

Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child...more
Listing Date
09 May, 2007(19 Years, 4 Months, 16 Days)
Chairperson NameLeo Puri